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Objective To examine the clinical pregnancy rate (CPR) and
multiple pregnancy rate (MPR) in a large in vitro fertilisation
(IVF) programme before and after the introduction of single
blastocyst transfer (SBT) strategy in a selected group of women.
Design A 3-year pre- and postintervention study.
Setting A tertiary reproductive medicine and assisted conception
unit in a London teaching hospital.
Population Two thousand four hundred and ﬁfty-one fresh IVF
cycles performed between July 2004 and June 2007 at the Assisted
Conception Unit at Guy’s and St Thomas’ Hospital NHS
Foundation Trust were included in the study.
Methods In January 2006, we implemented a multidisciplinary
intervention involving the introduction of a selective day 5 SBT
service together with an educational programme on the risks of
multiple pregnancy and potential advantages of blastocyst transfer
aimed at couples at high risk of multiple pregnancy.
Main outcome measures The CPR per cycle started and MPR per
clinical pregnancy achieved.
Results A statistically signiﬁcant increase in the CPR from 27%
(324/1198) to 32% (395/1253) (risk difference [RD] 5%, risk ratio
[RR] 1.17, 95% CI 1.03–1.32, P = 0.015) and reduction in the
MPR per clinical pregnancy from 32% (103/272) to 17% (69/395)
(RD 15%, RR 0.46, 95% CI 0.35–0.60, P < 0.001) were observed
after introduction of the SBT service.
Conclusion Selective SBT in women with good prognosis can
reduce the MPR after IVF while maintaining the overall success
rate of the IVF programme.
Keywords Blastocyst transfer, clinical pregnancy, IVF, multiple
pregnancy, single embryo transfer pregnancy.
Please cite this paper as: Khalaf Y, El-Toukhy T, Coomarasamy A, Kamal A, Bolton V, Braude P. Selective single blastocyst transfer reduces the multiple pregnancy
rate and increases pregnancy rates: a pre- and postintervention study. BJOG 2008;115:385–390.
Introduction
IVF treatment is well established in the contemporary man-
agement of infertility and currently accounts for 1% of the
total births in the UK.1 Due to the practice of transferr-
ing more than one embryo to maximise the chance of
pregnancy, the incidence of multiple pregnancy after IVF
treatment has risen to over 25%, nearly 20 times higher
than would be expected after spontaneous conception.2
Compared with singletons, twins have a seven-fold increase
in neonatal mortality and six-fold increase in the risk of cere-
bral palsy.3 Maternal morbidity and mortality rates and costs
to the health service are also increased.3–6 As a result, multiple
pregnancy is now considered the single most important risk
of IVF treatment.7–9
It has been recognised that the only effective method to
reduce the multiple pregnancy rate (MPR) after IVF is to
adopt a policy of single embryo transfer (SET).10–13 An expert
panel commissioned by the Human Fertilisation and Embry-
ology Authority in 2005 to review the evidence on multiple
births and SET proposed that IVF clinics should develop cri-
teria for selecting groups of women who should be offered
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or its potential effect on a clinic’s overall results was not
provided.
A potential risk to implementation of an SET policy is the
decline in pregnancy rate per IVF cycle started.14,15 A
Cochrane Review published in 200415 showed that transfer
of a single cleavage-stage (day 2 or 3) embryo versus two
cleavage-stage embryos resulted in a reduction in the MPR
(risk ratio [RR] 0.12, 95% CI 0.03–0.43, P = 0.0008), but with
a concurrent reduction in the clinical pregnancy rate (CPR)
(RR 0.68, 95% CI 0.52–0.9, P = 0.006).
Recent evidence suggests that transfer of a single blastocyst
on day 5 of in vitro culture is associated with a higher CPR
compared with transfer of a single cleavage-stage embryo.16
Extension of culture until day 5 aids the identiﬁcation of
those embryos likely to have the highest implantation and
pregnancy potential.17 These two studies,16,17 however, were
restricted to a highly selected group of women with good
prognosis, whereas the wider implications of adopting this
policy on the overall results in an IVF programme have not
been studied.18,19
In this study, we aimed to examine the impact of imple-
menting a single blastocyst transfer (SBT) strategy in
a selected group of women with good prognosis on the effec-
tiveness of a large IVF programme. We hypothesised that the
CPR would be maintained and the MPR would be signiﬁ-
cantly reduced.
Materials and methods
The study was conducted at the Assisted Conception Unit at
Guy’s and St Thomas’ Hospital; a tertiary referral centre per-
forming around 1000 IVF and intracytoplasmic sperm injec-
tion (ICSI) cycles per year.
Study population
Between July 2004 and June 2007, all IVF/ICSI cycles per-
formed in our unit were included. These cycles were divided
into two groups—July 2004 to December 2005 (n = 1198) and
January 2006 to June 2007 (n = 1253)—based on the embryo
culture and transfer strategy during each period. Cycles
involving preimplantation genetic diagnosis or the use of
donated oocytes or cryopreserved embryos were excluded.
Each couple gave written informed consent to the use of their
data for analysis upon entering our IVF programme.
Ovarian stimulation and IVF/ICSI
Our protocol for ovarian stimulation has been described else-
where.20 Human chorionic gonadotrophin (hCG) 6500 iu
(Ovitrelle; Serono Ltd, Middlesex, UK) was administered
to induce oocyte maturation when at least three follicles
had reached a mean diameter of ‡18 mm. Transvaginal
oocyte retrieval was carried out 35–36 hours later using an
ultrasound scanner with a 6.5 MHz probe (Hitachi EUB 525;
Hitachi, Tokyo, Japan).
For IVF cycles, oocytes were examined for evidence of nor-
mal fertilisation 16–18 hours after insemination, with the
identification of two pronuclei. For ICSI cycles, following
removal of cumulus/corona cells, mature (metaphase II)
oocytes were injected with a single, immobilised spermato-
zoon and examined for survival and normal fertilisation 16
hours after injection. Culture of gametes and embryos was
carried out using SAGE culture media (Rochford Medical,
Oxford, UK) under oil at 37 C in an atmosphere of 5%
CO2 in air.
Embryo culture and transfer strategies
Between July 2004 and December 2005 (2004/2005) up to
three cleavage-stage embryos were transferred to the uterus
2–3 days after insemination using an Edwards–Wallace
embryo transfer catheter (Sims Portex Ltd, Hythe, Kent,
UK). Between January 2006 and June 2007 (2006/2007),
cycles in which there were a minimum of four 8-cell cleav-
age-stage embryos with less than 10% cytoplasmic fragmen-
tation21,22 on day 3 were offered extended embryo culture
until day 5 to allow further development of these embryos
and transfer of a single blastocyst if a high-quality blastocyst17
was present. We continued to offer transfer of up to three
embryos for women where the cohort of embryos did not
satisfy these criteria. Apart from the introduction of extended
embryo culture and SBT for the women with good prognosis,
no other changes in our clinical protocols took place.
All women who underwent embryo transfer received sup-
plemental progesterone pessaries (Cyclogest; Shire Pharma-
ceuticals Ltd, Hants, UK) 400 mg daily throughout the luteal
phase and until 8 weeks of gestation if pregnancy occurred.
Patient education
To allow for the successful implementation of the SBT strat-
egy, audiovisual and written educational information regard-
ing the risks of multiple pregnancy and advantages of SBT was
given to all women at a monthly patient information seminar
as well as during one to one consultations. The rationale
behind our strategy was also displayed ona wall poster located
in the participants’ waiting area, together with regularly
updated results. Women who were eligible for extended
embryo culture and SBT were contacted on day 3 of culture
to ensure they understood their options and to discuss any
remaining concerns they might have.
Outcome measures
The study outcome measures were the CPR per cycle started
and MPR per clinical pregnancy achieved. Pregnancy was
conﬁrmed by a positive urine hCG test 16 days after oocyte
retrieval. A clinical pregnancy was deﬁned as the presence of
fetal heart activity detected by ultrasound 3 weeks after the
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number of gestational sacs observed on ultrasound scanning
divided by the number of embryos transferred.
Statistical analysis
In this centre, IVF/ICSI cycle data are prospectively collected
and stored in a relational database (FileMaker Pro 6.4; File-
Maker Inc, Santa Clara, CA, USA). Cycles performed in
2004/2005 (before implementation of the SBT strategy) were
compared with those performed in 2006/2007 (when SBT
strategy was introduced). Statistical analysis was performed
using t test or Mann–Whitney U test for continuous variables
as appropriate and chi-square test for discrete variables. Stat-
view software package (Abacus Concepts Ltd, Berkeley, CA,
USA) was used for statistical analysis. Statistical signiﬁcance
was set at P <0 . 0 5 .
Results
During the entire study period, 2451 fresh IVF/ICSI cycles
were started, 2086 (85%) cycles reached embryo transfer
and 3890 embryos were replaced (mean of 1.86 ± 0.46 embryo
per transfer). The overall CPR per cycle started was 29.3%
(719/2451) and the MPR per clinical pregnancy was 24%
(172/719) (Table 1). The CPR was similar in cycles in which
IVF (n = 1076) or ICSI (n = 1375) was used for oocyte in-
semination (30 versus 29%, respectively, RR 1.05, 95% CI
0.93–1.19, P = 0.5).
In 2004/2005 (preintervention period), 1198 fresh IVF/
ICSI cycles were performed, of which 994 (83%) reached em-
bryo transfer. The CPR per cycle started was 27% (324/1198)
and the MPR was 32% (103/324) per clinical pregnancy
(Table 1). In 2006/2007 (postintervention period), 1253 fresh
IVF/ICSI cycles were performed, of which 1092 (87%)
reached embryo transfer. The CPR per cycle started was
32% (395/1253) and the MPR was 17% (69/395) per clinical
pregnancy.
Day 5 culture and blastocyst transfer
All cycles that had extended embryo culture had at least one
blastocyst available for transfer on day 5. The percentage of
IVF/ICSI cycles having a blastocyst transfer in the study
increased from 0% (0/1198) in 2004/2005 to 17% (211/
1253) per cycle started and 19% (211/1092) per embryo trans-
fer in 2006/2007. The percentage of cycles opting to have a
blastocyst transfer also increased from 16% of transfers
(82/521) between January and September 2006 to 23%
(129/571) between October 2006 and June 2007 (RR 1.5,
95% CI 1.1–1.9, P = 0.003). Of the 211 blastocyst transfers
performed in the study, 137 (65%) were SBT.
Single embryo transfer
The percentage of cycles having SET in the study increased
from 13%perembryo transfer (127/994) in 2004/2005 to 23%
(250/1092) per transfer in 2006/2007 (RR 1.8, 95% CI 1.5–2.2,
P < 0.001). The proportion of IVF cycles where a single
embryo was transferred electively and surplus embryos cryo-
preserved altered signiﬁcantly from 1.9% of all cycles achiev-
ing surplus embryos cryopreservation (5/263) in 2004/2005
to 38% (129/342) in 2006/2007 (RR 21.9, 95% CI 9.1–52.7,
P <0.001). Of the 129 elective SET in 2006/2007, 118 (92%)
were elective SBT on day 5. Consequently, the mean number
Table 1. Characteristics of treatment cycles performed during the study period
Characteristic 2004/2005 (n 5 1198) 2006/2007 (n 5 1253) Difference (95% CI) P value
Age (years) 35.2 (4.5) 35.8 (4.4) 20.59 (20.94 to 2.0.24) 0.001
IVF cycle order 1.7 (1.0) 1.7 (1.1) 0.016 (20.1 to 0.069) 0.71
Basal FSH level (iu/l) 6.5 (2.4) 7.3 (2.7) 20.82 (21.03 to 20.62) 0.0001
Basal estradiol level (pmol/l) 173 (159) 169 (110) 4.1 (27.4 to 15.6) 0.49
Duration of stimulation, days 10.1 (1.7) 10.4 (1.9) 20.29 (20.43 to 20.15) 0.0001
Daily dose of FSH (iu) 281 (105) 281 (101) 0.24 (27.9 to 8.4) 0.95
Number of oocytes collected 10.3 (6.6) 11.2 (7.4) 20.84 (21.4 to 20.27) 0.004
Cycles reaching ET (%) 83 87 0.004
Day 5 selective SBT (%) –– 9 ,0.0001
Number of embryos replaced per transfer 1.9 (0.4) 1.8 (0.5) 0.07 (0.03 to 0.11) 0.0002
Cycles achieving freezing (%) 22 28 ,0.001
Pregnancy rate/cycle (%) 33 38 0.013
CPR/cycle (%) 27 32 0.015
Implantation rate (%) 25 28 0.11
MPR (%) 32 17 ,0.001
ET, embryo transfer; FSH, follicle-stimulating hormone; SBT, single blastocyst transfer.
Values are expressed as mean (SD) unless indicated otherwise.
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programme from 1.9 ± 0.4 embryos in 2004/2005 to 1.8 ± 0.5
embryos (P < 0.001). As a result of transferring fewer
embryos, the proportion of cycles achieving cryopreservation
of surplus embryos increased from 22% (267/1198) to 28%
(341/1224, RD = 6%, RR 1.3, 95% CI 1.09–1.44, P = 0.0015).
Analysis of outcome measures
Clinical pregnancy rate
TheoverallCPRpercyclestartedwashigherin2006/2007(32%,
395/1253) than in 2004/2005 (27%, 324/1198, RD = 5%, RR
1.17, 95% CI 1.03–1.32, P = 0.015). The improvement in the
CPR was observed in cycles where women’s age was less than
40 years (35% [352/1014] versus 30% [303/1026], RD = 5%,
RR 1.18, 95% CI 1.04–1.33, P = 0.012) and in those where
women’s age was 40 years or more (18% [43/239] versus 12%
[21/172], RD = 6%, RR 1.5, 95% CI 0.91–2.39, P = 0.11,
Table 2). The increase in the CPR was due to a higher CPR
per transfer (49%, 104/211) in the group of women who had
a blastocyst transfer. The CPR in cycles where day 2 or 3
cleavage-stage embryos were transferred was similar in
2004/2005 and 2006/2007 (32.6 versus 33%, respectively,
RR 1.01, 95% CI 0.89–1.15, P = 0.84).
Multiple pregnancy rate
The MPR throughout the study period decreased by 47%
from 32% (103/324) in 2004/2005 to 17% after introduction
of the SBT strategy in 2006/2007 (69/395, RD = 15%, RR 0.46,
95% CI 0.35–0.60, P<0.001) (Table 2 and Figure 1). Most of
the multiple pregnancies in 2004/2005 (100/103) occurred in
cycles performed for women younger than 40 years of age and
the risk was highest (41%, 49/121) in cycles where surplus
embryos were available for cryopreservation. In 2004/2005,
women in this group (women younger than 40 years and
surplus embryos available for cryopreservation) were not rou-
tinely offered the option of an SET, and in only 2% (4/246) of
their transfers, a single embryo was replaced electively. The
percentage of elective SET changed signiﬁcantly in 2006/2007.
Of the 316 transfers in the corresponding group in 2006/2007,
40% (125/316) were elective SET. As a result, the MPR in this
group dropped by 61% from 41 to 16% (28/174, RD = 25%,
RR 0.40, 95% CI 0.27–0.59, P < 0.001).
In addition, with the increase in the proportion of cycles
that opted for blastocyst transfer from 16% in the ﬁrst half of
2006/2007 (January to September 2006) to 23% in the second
half of 2006/2007 (October 2006 to June 2007, P = 0.003), the
MPR showed a concomitant (but nonsigniﬁcant) reduction
from 20%(39/190) to 15% (30/205),respectively (RD 5%, RR
0.72, 95% CI 0.46–1.1, P = 0.13, Figure 1).
Discussion
The goal of any fertility treatment should be the birth of a
healthy singleton infant.10 Although the effectiveness of SET in
reducing the MPR after IVF has been demonstrated,11–13 the
main challenge is to achieve this reduction while maintaining
the overall success rate within the entire IVF programme.
Women with good prognosis, deﬁned in our study as those
who have at least four 8-cell embryos with less than 10%
cytoplasmic fragmentation, not only have the best chance of
producing blastocysts on day 5 of culture but are also at
greatest risk of multiple pregnancy if two embryos are trans-
ferred.13,23 Extension of embryo culture till day 5 aids the
Table 2. CPR and MPR in different age groups before and after introducing SBTservice
Age group
(years)
CPR (%) P value MPR (%) P value
Before SBT (2004/2005) After SBT (2006/2007) Before SBT (2004/2005) After SBT (2006/2007)
,35 35 (185/527) 41 (202/496) 0.06 38 (71/185) 19 (38/202) ,0.0001
35–37 27 (88/332) 33 (101/309) 0.08 25 (22/88) 19 (19/101) 0.30
38–39 18 (30/167) 23 (49/209) 0.19 23 (7/30) 14 (7/49) 0.30
40 12 (21/172) 18 (43/239) 0.11 14 (3/21) 12 (5/43) 0.76
Total 27 (324/1198) 32 (395/1253) 0.015 32 (103/324) 17 (69/395) ,0.001
Values are expressed as percentages.
Figure 1. Effect of introduction of SBT policy.
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implant. As a result, a high pregnancy rate might be expected
after transferring a single blastocyst.16
To our knowledge, this is the ﬁrst study to examinethe effects
of applying an SBT strategy in a selected group of good prog-
nosis women on the overall results of a large IVF programme.
We compared the CPR per cycle started and the MPR per
clinical pregnancy achieved during an 18-month period before
and after introduction of the SBT service in our IVF pro-
gramme. The objective from introducing this service was to
signiﬁcantly reduce the MPR by at least one-third,5 thereby
reducing the morbidity and mortality of babies and mothers.
The present study provides evidence that education and
appropriate selection of participants can achieve a reduction
in the MPR by almost 50% without compromising the effec-
tiveness of the IVF programme. In fact, we observed an
increase in the CPR after introduction of the SBT service
despite an increase in women’s mean age and basal follicle-
stimulating hormone level, mainly due to identiﬁcation of
embryos with the highest implantation potential through
extended culture.16,17 The increase in the CPR attests to the
signiﬁcant potential of elective SBT to reduce the risk of mul-
tiple pregnancy when applied judiciously. Although only one
in 11 (118/1253) cycles started in 2006/2007 had an elective
SBT, a dramatic reduction in the MPR was achieved since
only cycles at high risk of multiple pregnancy were selected.
Our data should, therefore, encourage other IVF pro-
grammes to develop similar strategies to lower their MPR
without fear of reduction in their IVF success rates. This
reassurance is particularly relevant in countries where the
majority of IVF treatment cycles are not state funded, mount-
ing more pressure on the treating physician to maximise each
patient’s chance of pregnancy per cycle.24–27 Only 19% of
cycles reaching embryo transfer satisﬁed our eligibility criteria
for extended culture and blastocyst transfer. In the next phase
of our strategy to further reduce the MPR, we intend to offer
extended culture and SBT in more cycles, by including those
with three (rather than four) 8-cell cleavage-stage embryos
with less than 10% cytoplasmic fragmentation on day 3 of
culture. Other clinics need to examine their patient’s charac-
teristics and laboratory performance and modify their selec-
tion criteria accordingly.24 Our experience could also pave the
way for the development of agreed national guidelines for
SET, similar to those already in place in several European
countries.28
Another advantage to this strategy is the increase in the
proportion of cycles where supernumerary embryos are avail-
able for cryopreservation. By replacing fewer embryos, and at
a stage where quality is deemed to be better, it is likely that
a larger proportion of cycles would have surplus embryos
suitable for cryopreservation. In our study, the percentage
of cycles achieving embryo cryopreservation increased by
30% (from 22 to 28%) after introducing the SBT service,
thereby maximising the cumulative chance of pregnancy from
a single cycle of ovarian stimulation and oocyte retrieval.12
The presence of a successful blastocyst freezing–thawing pro-
gramme would further encourage women to choose the
option of SBT and cryopreserve supernumerary embryos.26,29
Finally, patient acceptability is central to the success of any
treatment modality.30 There is evidence that multiple pregn-
ancy is a frequently desired outcome of treatment by infertile
women.31,32 It was therefore critical in our strategy to ensure
that women are fully informed about the beneﬁts of SBT and
risks of twin pregnancy and to promote a safe practice of SET.
Audiovisual and written information was disseminated to our
women for this purpose, leading to sustained increase in
patient acceptability to the SBT policy in 2006/2007. This
paradigm shift in acceptance of SET concurs with recent
research highlighting the importance of couples’ education
in changing their attitude towards what is regarded as a de-
sired IVF treatment outcome.33
In conclusion, introducing an SBT service aimed at women
with good prognosis has enabled us to almost half the MPR
and improved the overall efﬁciency of the entire IVF pro-
gramme. The key elements behind the success of this strategy
were selection and education of women at high risk of mul-
tiple pregnancy. j
References
1 European Society Human Reproduction and Embryology. Assisted
reproduction technology in Europe, 2000. Results generated from
European registers by ESHRE. Hum Reprod 2004;19:490–503.
2 HFEA register data 2003/2004. [www.hfea.gov.uk]. Accessed 1 June
2007.
3 El-Toukhy T, Khalaf Y, Braude P. IVF results: optimise not maximise.
Am J Obstet Gynecol 2006;194:322–31.
4 Walker M, Murphy K, Pan S, Yang Q, Wen S. Adverse maternal out-
comes in multifetal pregnancies. BJOG 2004;111:1294–6.
5 Pinborg A. IVF/ICSI twin pregnancies: risks and prevention. Hum
Reprod Update 2005;11:575–93.
6 Ledger W, Anumba D, Marlow N, Thomas C, Wilson E. Cost of Multiple
Births Study Group (COMBS Group). The costs to the NHS of multiple
births after IVF treatment in the UK. BJOG 2006;113:21–5.
7 ESHRE Campus Course Report. Prevention of twin pregnancies after
IVF/ICSI by single embryo transfer. Hum Reprod 2001;16:790–800.
8 ESHRE Task Force on Ethics and Law. 6. Ethical issues relatedto multiple
pregnancies in medically assisted procreation. Hum Reprod 2003;18:
1976–9.
9 Hamilton M. Multiple births in the United Kingdom––a consensus
statement. Hum Fertil 2007;10:71–4.
10 BraudeP.ReportoftheexpertgrouponmultiplebirthsafterIVF.Onechild
at a time. 2006 [www.hfea.gov.uk\docs\MBSET_report_Final_Dec_06.
pdf]. Accessed 2 February 2007.
11 MartikainenH,TiitinenA,TomasC,TapanainenJ,OravaM,TuomivaaraL,
et al. One versus two embryo transfer after IVF and ICSI: a randomised
study. Hum Reprod 2001;16:1900–3.
12 Thurin A, Hausken J, Hillensjo T, Jablonowska B, Pinborg A, Strandell A,
et al. Elective single-embryo transfer versus double-embryo transfer
in in vitro fertilization. N Engl J Med 2004;351:2392–402.
Selective SBT reduces MPR and increases the CPR
ª 2008 The Authors Journal compilation ª RCOG 2008 BJOG An International Journal of Obstetrics and Gynaecology 38913 Lukassen H, Braat D, Wetzels A, Zielhuis G, Adang E, Scheenjes E, et al.
Two cycles with single embryo transfer versus one cycle with double
embryo transfer: a randomised controlled trial. Hum Reprod 2005;
20:702–8.
14 Gleicher N, Barad D. The relative myth of elective single embryo trans-
fer. Hum Reprod 2006;21:1337–44.
15 PandianZ,BhattacharyaS,OzturkO,SerourGI,TempletonA.Numberof
embryos for transfer following in-vitro fertilisation or intra-cytoplasmic
sperm injection. Cochrane Database Syst Rev 2004:CD003416.
16 Papanikolaou EG, Camus M, Kolibianakis EM, Van Landuyt L,
Van Steirteghem A, Devroey P. In vitro fertilization with single
blastocyst-stage versus single cleavage-stage embryos. N Engl J Med
2006;354:1139–46.
17 Gardner D, Surrey E, Minjarez D, Leitz A, Stevens J, Schoolcraft W.
Single blastocyst transfer: a prospective randomised trial. Fertil Steril
2004;81:551–5.
18 van Montfoort AP, Fiddelers AA, Janssen JM, Derhaag JG, Dirksen CD,
Dunselman GA, et al. In unselected patients, elective single embryo
transfer prevents all multiples, but results in signiﬁcantly lower preg-
nancy rates compared with double embryo transfer: a randomized
controlled trial. Hum Reprod 2006;21:338–43.
19 Anonymous. Assisted reproductive technology in the United States:
2001 results generated from the American Society for Reproductive
Medicine/Society for Assisted Reproductive Technology registry. Fertil
Steril 2007;87:1253–66.
20 El-Toukhy T, Khalaf Y, Hart R, Taylor A, Braude P. Young age does not
protect against the adverse effects of reduced ovarian reserve––an
eight year study. Hum Reprod 2002;17:1519–24.
21 Van Royen E, Mangelschots K, De Neubourg D, Valkenburg M, Van de
Meerssche M, Ryckaert G, et al. Characterisation of a top quality
embryo, a step towards single-embryo transfer. Hum Reprod 1999;14:
2345–9.
22 Papanikolaou EG, D’haeseleer E, Verheyen G, Van der Velde H, Camus
M, Van Steirteghem A, et al. Live birth rate is signiﬁcantly higher after
blastocyst transfer than after cleavage stage embryo transfer when at
least 4 embryos are available on day 3 of embryo culture. A random-
ised prospective study. Hum Reprod 2005;20:3198–203.
23 Templeton A, Morris JK. Reducing the risk of multiple births by transfer
of two embryos after in vitro fertilisation. N Engl J Med 1998;339:
573–7.
24 VelevaZ,VilskaS,Hyden-GranskogC,TiitinenA,TapanainenJS,Martikainen
H. Elective single embryo transfer in women aged 36-39 years. Hum
Reprod 2006;21:2098–102.
25 Scotland G, McNamee P, Peddie V, Bhattacharya S. Safety versus
success in elective single embryo transfer: women’s preferences for
outcomes of in vitro fertilisation. BJOG 2007;114:977–83.
26 Lieberman B, Ali R, Rangarajan S. Towards the elective replacement
of a single embryo (eSET) in the United Kingdom. Hum Fertil 2007;
10:123–7.
27 Scotland G, McNamee P, Bhattacharya S. Is elective single embryo
transfer a cost-effective alternative to double embryo transfer? BJOG
2007;114:5–7.
28 Gerris J. Single embryo transfer and IVF/ICSI outcomes: a balanced
appraisal. Hum Reprod Update 2005;11:105–21.
29 Henman M, Catt JW, Wood T, Bowman M, de Boer K, Jansen R. Elec-
tive transfer of single fresh blastocysts and later transfer of cryostored
blastocysts reduces the twin pregnancy rate and can improve the
in vitro fertilization live birth rate in younger women. Fertil Steril
2005;84:1620–7.
30 Murray S, Shetty A, Rattray A, Taylor V, Bhattacharya S. A randomised
comparison of alternative methods of information provision on the
acceptability of elective single embryo transfer. Hum Reprod 2004;19:
911–16.
31 Ryan G, Zhang S, Dokras A, Syrop C, Van Voorhis B. The desire of
infertile patients for multiple births. Fertil Steril 2004;81:500–4.
32 Child T, Henderson A, Tan SL. The desire for multiple pregnancy
in male and female infertility patients. Hum Reprod 2004;19:
558–61.
33 Coetzee K, Stewart B, Peek J, Hutton J. Acceptance of single-embryo
transfer by patients. Fertil Steril 2007;87:207–9.
Khalaf et al.
390 ª 2008 The Authors Journal compilation ª RCOG 2008 BJOG An International Journal of Obstetrics and Gynaecology